Mass Drug Administration With High-Dose Ivermectin and Dihydroartemisinin-Piperaquine for Malaria Elimination in an Area of Low Transmission With High Coverage of Malaria Control Interventions: Protocol for the MASSIV Cluster Randomized Clinical Trial

Mass Drug Administration With High-Dose Ivermectin and Dihydroartemisinin-Piperaquine for Malaria Elimination in an Area of Low Transmission With High Coverage of Malaria Control Interventions: Protocol for the MASSIV Cluster Randomized Clinical Trial

BackgroundWith a decline in malaria burden, innovative interventions and tools are required to reduce malaria transmission further. Mass drug administration (MDA) of artemisinin-based combination therapy (ACT) has been identified as a potential tool to further reduce malaria transmission, where cove...

Full description

Bibliographic Details
Main Authors: Dabira, Edgard Diniba, Soumare, Harouna M, Lindsay, Steven W, Conteh, Bakary, Ceesay, Fatima, Bradley, John, Kositz, Christian, Broekhuizen, Henk, Kandeh, Balla, Fehr, Alexandra E, Nieto-Sanchez, Claudia, Ribera, Joan Muela, Peeters Grietens, Koen, Smit, Menno Roderick, Drakeley, Chris, Bousema, Teun, Achan, Jane, D’Alessandro, Umberto
Format: Article
Language:English
Published: JMIR Publications 2020-11-01
Series:JMIR Research Protocols
Online Access:https://www.researchprotocols.org/2020/11/e20904

Internet

https://www.researchprotocols.org/2020/11/e20904

Similar Items